Find your next paid study

City of Hope Medical CenterNCT06314958

~$10 – $750

Actual pay is set by the research site.

Advanced Solid TumorsNSCLC AdenocarcinomaCholangiocarcinoma+2 more

A Phase 1, First-in-Human, Open Label, Dose Escalation and Cohort Expansion Study of MGC028 in Participants With Advanced Solid Tumors

The goal of this clinical trial is to characterize the safety, tolerability, dose-limiting toxicities (DLT), and maximum tolerated dose (MTD) or maximum admini…

Alcohol Use Disorder (AUD)Withdrawal From Addictive Substance; DetoxificationCraving

Actual pay is set by the research site.

MacroGenicsNCT06723236

Phase 2

Cannabidiol as an Adjunct Treatment for Alcohol Withdrawal and Craving

Cannabidiol (CBD), one of the most prevalent cannabinoids in cannabis (marijuana) has been shown to reduce alcohol withdrawal symptoms in laboratory animals. I…

Johns Hopkins UniversityNCT07148843

~$75 – $2,000

Actual pay is set by the research site.

Observational

WearLinq eWave Patch Study

This study it to evaluate the usability of the WearLinq eWave patch in a general adult population.

Healthy Adult ParticipantsHeart DiseaseArrythmia+1 more

~$10 – $1,125

Actual pay is set by the research site.

WearlinqNCT07388355

MigraineMigraine DiseaseMigraine in Adults+4 more

A Prospective, Open-Label Study Evaluating the Effectiveness of Rimegepant ODT or Zavegepant Nasal Spray for Acute Treatment of Migraine in the Emergency Department

Prospective, single-site, open-label, non-controlled pilot study consisting of two parallel trials. Participants will receive rimegepant or zavegepant for acut…

University of South FloridaNCT07667621

~$500 – $7,500

Actual pay is set by the research site.

A Phase 1, Multicenter, Open-Label Clinical Study to Evaluate the Safety and Tolerability of GS-2426 in Participants With Advanced MTAP-Deleted Solid Tumors

The goal of this clinical study is to learn more about the study drug GS-2426, and how safe and tolerable it is in participants with advanced methylthioadenosi…

Advanced Solid Tumors

Gilead SciencesNCT07601243

Actual pay is set by the research site.

Imaging Predictors of Cryolysis Efficacy for Treatment of Obstructive Sleep Apnea

The goal of this observational study is to further evaluate the efficacy and mechanism of action of the Cryosa Procedure, a novel procedure intended to treat o…

Obstructive Sleep Apnea of Adult

University of PennsylvaniaNCT06434558

~$10 – $750

Actual pay is set by the research site.

MeningiomaGlioblastomaAcoustic Neuroma+2 more

Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures

This pilot clinical study evaluates the safety and imaging performance of panitumumab-IRDye800 (pan800), a fluorescent, EGFR-targeted imaging agent - in patien…

Eben RosenthalNCT07493447

Actual pay is set by the research site.

Observational

Comparing the Efficacy of Heated Yoga and Sauna as a Treatment for Depression

This project explores whether heated yoga, sauna, and a mindfulness app reduce depressive symptoms

Depression DisordersDepression - Major Depressive DisorderDepression Disorder+3 more

Massachusetts General HospitalNCT07082998

~$10 – $750

Actual pay is set by the research site.

Advanced/Metastatic Non-Small Cell Lung CancerCarcinoma, Non-Small Cell LungNon-Small Cell Lung Cancer

AN INTERVENTIONAL OPEN-LABEL PHASE 1B/2 STUDY TO EVALUATE THE SAFETY, PHARMACOKINETICS, AND PRELIMINARY EFFICACY OF PF-08634404 IN COMBINATION WITH DIFFERENT ANTICANCER AGENTS IN PARTICIPANTS WITH ADVANCED SOLID TUMORS

This study is being done to learn more about a new medicine called PF-08634404 and how it works when used with other cancer medicines in people who have advanc…

Astrocytoma, IDH-Mutant, Grade 3

Actual pay is set by the research site.

PfizerNCT07227298

Phase 3

Phase III Trial of Radiotherapy Followed by Adjuvant Temozolomide in Combination With the IDH Inhibitor Vorasidenib vs Placebo in IDH-Mutated Newly-Diagnosed Grade 3 Astrocytomas

This phase III trial compares the effect of vorasidenib to placebo in combination with usual treatment, temozolomide, in treating patients with newly diagnosed…

Alliance for Clinical Trials in OncologyNCT07215910

~$50 – $1,500

Actual pay is set by the research site.

Advanced Solid TumorCutaneous TumorSubcutaneous Tumor+6 more

A Phase I Open-Label, Dose Escalation Study of the Safety and Tolerability of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors

This is a Phase 1, multicenter, open-label dose escalation study to determine the safety and tolerability of intratumoral (IT) injection of tolododekin alfa (A…